West Pharmaceutical Services (WST) Earnings Analysis

West Pharmaceutical Services (WST) next reports earnings on 2026-10-22, consensus EPS 2.14 USD. Last quarter (2026-07-23) it beat with EPS 2.37 USD vs 2.08 USD est (+13.9%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 47.70.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does WST next report earnings?

Next earnings date2026-10-22
Consensus EPS estimate2.14 USD
Revenue estimate0.81B

WST earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-232.37 USD2.08 USD+13.9%Beat
2026-04-232.13 USD1.68 USD+26.8%Beat
2026-02-122.04 USD1.83 USD+11.5%Beat
2025-10-231.96 USD1.68 USD+16.7%Beat
2025-07-241.84 USD1.51 USD+21.9%Beat
2025-04-241.45 USD1.22 USD+18.9%Beat
2025-02-131.82 USD1.71 USD+6.4%Beat
2024-10-241.85 USD1.5 USD+23.3%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

WST valuation and analyst view

Trailing P/E47.70
Trailing EPS7.538 USD
Price / book8.64
Dividend yield0.24%
Market cap25.32B
Analyst consensusBuy (11 buy / 3 hold / 1 sell)
Avg price target376.71 USD

Related research pages

Frequently asked questions

When is West Pharmaceutical Services (WST)'s next earnings date?

West Pharmaceutical Services is next scheduled to report on 2026-10-22, with a consensus EPS estimate of 2.14 USD and revenue estimate of 0.81B.

Did WST beat earnings last quarter?

In its 2026-07-23 report, WST posted EPS of 2.37 USD versus a 2.08 USD estimate — a beat of 13.9%.

What is WST's earnings track record?

Over the last 8 reported quarters with consensus data, WST beat estimates 8 times (100%).

What is WST's current P/E ratio and EPS?

WST trades at a trailing P/E of 47.70 on trailing EPS of 7.5375 USD.

What do analysts rate WST?

Analyst consensus is "Buy" across 15 ratings (0 strong buy, 11 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 376.71 USD.